An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 10 Sponsors

No sponsors recorded.

PASSAGE PROBABILITY

12.1% Unlikely

Why this number

Stage base Passed First Chamber — base rate 19%, measured from PA's completed sessions
Momentum +4 69/100 from the pace of recorded action
Time since last action -11 93 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.